SARS-CoV-2 Spike-Derived Peptides Presented by HLA Molecules

SARS-CoV-2 Spike-Derived Peptides Presented by HLA Molecules

The SARS-CoV-2 virus responsible for the COVID-19 pandemic has caused significant morbidity and mortality worldwide. With the remarkable advances in medical research, vaccines were developed to prime the human immune system and decrease disease severity. Despite these achievements, the fundamental b...

Full description

Bibliographic Details
Main Authors:	Andrea T. Nguyen, Christopher Szeto, Dhilshan Jayasinghe, Christian A. Lobos, Hanim Halim, Demetra S. M. Chatzileontiadou, Emma J. Grant, Stephanie Gras
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Biophysica
Subjects:	SARS-CoV-2 HLA peptide presentation structural biology spike protein
Online Access:	https://www.mdpi.com/2673-4125/1/2/15

Similar Items

Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR
by: Christopher Szeto, et al.
Published: (2021-10-01)

Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition
by: Christopher Szeto, et al.
Published: (2020-09-01)

Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides
by: Demetra S.M. Chatzileontiadou, et al.
Published: (2021-09-01)

Homologous peptides derived from influenza A, B and C viruses induce variable CD8+ T cell responses with cross‐reactive potential
by: Andrea T Nguyen, et al.
Published: (2022-01-01)

The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
by: Jiji V. D. Attia, et al.
Published: (2020-11-01)

Empirical Evaluation of the Use of Computational HLA Binding as an Early Filter to the Mass Spectrometry-Based Epitope Discovery Workflow
by: Rachid Bouzid, et al.
Published: (2021-05-01)

Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction
by: Mareike Wendorff, et al.
Published: (2020-08-01)

Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance
by: Máté Manczinger, et al.
Published: (2018-07-01)

HLA-A29 and Birdshot Uveitis: Further Down the Rabbit Hole
by: Jonas J. W. Kuiper, et al.
Published: (2020-11-01)

HLA-H: Transcriptional Activity and HLA-E Mobilization
by: François Jordier, et al.
Published: (2020-01-01)

TCR Recognition of Peptide–MHC-I: Rule Makers and Breakers
by: Christopher Szeto, et al.
Published: (2020-12-01)

Differences in F pocket impact on HLA I genetic associations with autoimmune diabetes
by: Xu Ren, et al.
Published: (2024-03-01)

HLA-DM focuses on conformational flexibility around P1 pocket to catalyze peptide exchange
by: Liusong eYin, et al.
Published: (2013-10-01)

Divergent Peptide Presentations of HLA-A*30 Alleles Revealed by Structures With Pathogen Peptides
by: Shiyan Zhu, et al.
Published: (2019-07-01)

Structural Basis for Unusual TCR CDR3β Usage Against an Immunodominant HIV-1 Gag Protein Peptide Restricted to an HLA-B*81:01 Molecule
by: Yang Liu, et al.
Published: (2022-01-01)

Modeling Peptide–Protein Interactions by a Logo-Based Method: Application in Peptide–HLA Binding Predictions
by: Irini Doytchinova, et al.
Published: (2024-01-01)

Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove
by: Curtis McMurtrey, et al.
Published: (2016-01-01)

THERMODYNAMICS OF PEPTIDE-MHC CLASS II INTERACTIONS: NOT ALL COMPLEXES ARE CREATED EQUAL
by: Andrea eFerrante
Published: (2013-10-01)

HLA class Ib molecules and immune cells in pregnancy and preeclampsia
by: Snezana eDjurisic, et al.
Published: (2014-12-01)

Effects of HLA single chain trimer design on peptide presentation and stability
by: Kathryn A. K. Finton, et al.
Published: (2023-05-01)

Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral–Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People
by: Hamid Reza Ghasemi Basir, et al.
Published: (2022-07-01)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
by: Adi Nagler, et al.
Published: (2021-06-01)

Inhibition of HLA-DM mediated MHC class II peptide loading by HLA-DO promotes self tolerance
by: Lisa K. Denzin
Published: (2013-12-01)

Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity
by: Mepur H. Ravindranath, et al.
Published: (2024-01-01)

A Fusion Peptide in the Spike Protein of MERS Coronavirus
by: Entedar A. J. Alsaadi, et al.
Published: (2019-09-01)

Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands
by: Marta A. S. Perez, et al.
Published: (2019-11-01)

Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes
by: Eli Olson, et al.
Published: (2023-02-01)

The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides
by: Gia-Gia T. Hò, et al.
Published: (2020-10-01)

Complementarity of binding motifs is a general property of HLA-A and HLA-B molecules and does not seem to effect HLA haplotype composition
by: Xiangyu eRao, et al.
Published: (2013-11-01)

Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19
by: Maxim Shkurnikov, et al.
Published: (2021-02-01)

HLA-E Peptide Repertoire and Dimorphism—Centerpieces in the Adaptive NK Cell Puzzle?
by: Alexander Rölle, et al.
Published: (2018-10-01)

The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
by: Michael D. Knierman, et al.
Published: (2020-12-01)

PepSim: T-cell cross-reactivity prediction via comparison of peptide sequence and peptide-HLA structure
by: Sarah Hall-Swan, et al.
Published: (2023-04-01)

Expression of the Non-classical HLA-E, -F, -G Molecules in the Tumour Microenvironment
by: Ormandjieva Anastasia
Published: (2023-08-01)

Enhancing cholangiocarcinoma immunotherapy with adoptive T cells targeting HLA-restricted neoantigen peptides derived from driver gene mutations
by: Aussara Panya, et al.
Published: (2023-12-01)

The Emerging Role of uORF-Encoded uPeptides and HLA uLigands in Cellular and Tumor Biology
by: Lara Jürgens, et al.
Published: (2022-12-01)

Understanding the Role of HLA Class I Molecules in the Immune Response to Influenza Infection and Rational Design of a Peptide-Based Vaccine
by: A. K. M. Muraduzzaman, et al.
Published: (2022-11-01)

Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
by: Stepan Nersisyan, et al.
Published: (2022-04-01)

HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease
by: Christophe Desterke, et al.
Published: (2021-07-01)

Unsupervised Mining of HLA-I Peptidomes Reveals New Binding Motifs and Potential False Positives in the Community Database
by: Chatchapon Sricharoensuk, et al.
Published: (2022-03-01)